Enhertu's New Role: Early Treatment Boost for Metastatic Breast Cancer

Insights from ASCO Annual Meeting on Enhertu and Advanced Treatment Strategies

Jul 11, 2024

∙ Paid

A detailed and realistic image depicting a healthcare setting focused on breast cancer treatment. The scene includes a doctor explaining new treatment options to a patient, with medical charts and breast cancer awareness symbols in the background. The doctor is holding a vial of medication, and there is a poster showing the molecular structure of a drug. The environment is a modern hospital room with medical equipment and an optimistic atmosphere, emphasizing care and advanced medical research.

Topline:

Enhertu (trastuzumab deruxtecan) shows promise in improving progression-free survival for women with HER2-low hormone receptor-positive metastatic breast cancer, suggesting earlier use in treatment protocols.

Study Details:

Recent findings presented at the American Society of Clinical Oncology (ASCO) annual meeting shed light on significant advanc…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.